Mahmood Textile Mills Limited (PSX:MEHT)

Theseus Pharmaceuticals Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	62	31.96	34.61	46.91	97.6	45.05
Trading Asset Securities	-	28.77	24.8	324.77	310.29	725.34
Cash & Short-Term Investments	96.04	60.73	59.41	371.68	407.9	770.39
Cash Growth	32.39%	2.22%	-84.02%	-8.88%	-47.05%	-44.77%
Accounts Receivable	7,713	6,724	6,145	6,281	2,650	3,103
Other Receivables	1,641	1,464	1,645	1,260	922.14	1,319
Receivables	9,354	8,188	7,790	7,541	3,572	4,422
Inventory	23,346	17,674	19,093	12,033	8,244	7,291
Other Current Assets	3,143	4,556	1,014	733.97	268.44	184.08
Total Current Assets	35,940	30,479	27,956	20,680	12,492	12,667
Property, Plant & Equipment	22,611	22,215	17,649	13,939	9,697	8,581
Long-Term Investments	2,206	2,074	5,539	5,114	4,610	4,190
Other Intangible Assets	58.98	16.04	4.85	6.92	-	-
Other Long-Term Assets	227.89	249.79	222.2	53.43	25.02	9.98
Total Assets	61,044	55,033	51,371	39,793	26,825	25,448
Accounts Payable	7,447	2,554	2,370	1,036	455.2	310.51
Accrued Expenses	711.17	2,997	3,141	1,795	1,154	897.43
Short-Term Debt	20,740	16,422	17,655	12,212	7,301	8,764
Current Portion of Long-Term Debt	2,114	2,064	1,708	1,172	980.89	180.49
Current Portion of Leases	-	8	8.56	6.25	2.41	-
Current Income Taxes Payable	961.56	1,077	769.68	594.17	320	262
Current Unearned Revenue	266.29	84.88	126.48	73.18	33.05	38.14
Other Current Liabilities	3.68	3,219	2,159	1,709	406.38	810.85
Total Current Liabilities	32,243	28,426	27,937	18,597	10,652	11,263
Long-Term Debt	10,122	8,375	9,064	7,962	5,817	5,498
Long-Term Leases	13.46	22.05	29.87	25.22	12.69	-
Long-Term Unearned Revenue	-	-	-	-	17.03	-
Long-Term Deferred Tax Liabilities	707.3	805.02	579.21	519.97	327.06	104.5
Other Long-Term Liabilities	-	-	6.3	38.47	60.78	-
Total Liabilities	43,086	37,628	37,616	27,142	16,887	16,865
Common Stock	300	300	300	187.5	187.5	187.5
Retained Earnings	12,153	11,410	11,058	9,927	7,074	5,597
Comprehensive Income & Other	5,506	5,695	2,397	2,537	2,676	2,798
Shareholders' Equity	17,959	17,405	13,755	12,651	9,938	8,583
Total Liabilities & Equity	61,044	55,033	51,371	39,793	26,825	25,448
Total Debt	32,989	26,891	28,465	21,377	14,113	14,442
Net Cash (Debt)	-32,893	-26,830	-28,406	-21,005	-13,706	-13,671
Net Cash Per Share	-1096.42	-894.35	-946.85	-700.16	-456.85	-455.71
Filing Date Shares Outstanding	29.99	30	30	30	30	30
Total Common Shares Outstanding	29.99	30	30	30	30	30
Working Capital	3,697	2,053	18.96	2,083	1,840	1,404
Book Value Per Share	598.74	580.17	458.49	421.73	331.27	286.09
Tangible Book Value	17,900	17,389	13,750	12,644	9,938	8,583
Tangible Book Value Per Share	596.78	579.64	458.33	421.50	331.27	286.09
Land	-	2,335	1,087	1,155	1,440	1,440
Buildings	-	5,366	5,472	4,045	2,977	2,950
Machinery	-	20,874	18,042	12,278	9,542	9,188
Construction In Progress	-	234.66	337.21	2,615	1,558	126.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.